Quarterly report [Sections 13 or 15(d)]

Stockholders' Equity (Tables)

v3.25.3
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2025
Equity [Abstract]  
Summary of Restricted Stock Activity

RSU activity for the nine months ended September 30, 2025 is summarized below:

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

average

 

 

 

 

 

 

 

 

 

 

 

 

grant

 

 

 

 

 

 

Performance

 

 

 

 

 

date fair

 

 

 

 

 

 

and

 

 

 

 

 

value

 

Restricted stock units

 

Time-based

 

 

time-based

 

 

Total

 

 

per share

 

Unvested restricted stock units as of December 31, 2024

 

 

1,203,383

 

 

 

601,194

 

 

 

1,804,577

 

 

$

8.61

 

Granted

 

 

1,005,224

 

 

 

822,308

 

 

 

1,827,532

 

 

 

9.12

 

Vested

 

 

(439,625

)

 

 

(118,100

)

 

 

(557,725

)

 

 

10.06

 

Forfeited/canceled

 

 

(132,114

)

 

 

(128,124

)

 

 

(260,238

)

 

 

9.69

 

Unvested restricted stock units as of September 30, 2025 (1)

 

 

1,636,868

 

 

 

1,177,278

 

 

 

2,814,146

 

 

$

8.47

 

Unvested and expected to vest restricted stock units outstanding as of
      September 30, 2025

 

 

 

 

 

 

 

 

1,940,089

 

 

$

8.40

 

(1) Outstanding RSUs are based on the maximum payout of the targeted number of shares.
Summary of Stock-based Compensation Expense

Stock-based compensation expense recognized for the three and nine months ended September 30, 2025 and 2024, was as follows:

 

 

 

Three months ended

 

 

Nine months ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Stock-based compensation expense by type of award:

 

 

 

 

 

 

 

 

 

 

 

 

Restricted stock units

 

$

1,693

 

 

$

1,362

 

 

$

5,906

 

 

$

5,367

 

Employee stock purchase plan

 

 

70

 

 

 

112

 

 

 

297

 

 

 

337

 

Total stock-based compensation expense

 

$

1,763

 

 

$

1,474

 

 

$

6,203

 

 

$

5,704

 

S

For the three and nine months ended September 30, 2025 and 2024, respectively, stock-based compensation expense recognized under ASC 718, included in cost of revenue, research and development expense, sales and marketing expense, and general and administrative expense was as follows:

 

 

Three months ended

 

 

Nine months ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Cost of revenue

 

$

135

 

 

$

123

 

 

$

431

 

 

$

448

 

Research and development

 

 

72

 

 

 

68

 

 

 

236

 

 

 

453

 

Sales and marketing

 

 

184

 

 

 

363

 

 

 

584

 

 

 

1,221

 

General and administrative

 

 

1,372

 

 

 

920

 

 

 

4,952

 

 

 

3,582

 

Total stock-based compensation expense

 

$

1,763

 

 

$

1,474

 

 

$

6,203

 

 

$

5,704